Innoviva to Participate in the Goldman Sachs Annual Global Healthcare Conference
07 June 2023 - 6:05AM
Business Wire
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified
holding company with a portfolio of royalties and other healthcare
assets, today announced that Pavel Raifeld, Chief Executive
Officer, will present at the Goldman Sachs Annual Global Healthcare
Conference in Dana Point, CA on Monday, June 12th, 2023 at 2:00
p.m. Pacific Time.
The presentation will be webcast and can be accessed under
“Events & Presentations” in the Investor Relations section of
the Company’s website at
https://investor.inva.com/presentations-events. The webcast will be
available for replay for 90 days following the event.
About Innoviva
Innoviva, Inc., is a diversified holding company with a
portfolio of royalties and other healthcare assets, including
Innoviva Specialty Therapeutics, a subsidiary focused on delivering
innovative therapies in critical care and infectious disease.
Innoviva’s royalty portfolio includes respiratory assets partnered
with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA®
(fluticasone furoate/vilanterol, FF/VI) and ANORO® ELLIPTA®
(umeclidinium bromide/vilanterol, UMEC/VI). Under the Long-Acting
Beta2 Agonist (LABA) Collaboration Agreement, Innoviva is entitled
to receive royalties from GSK on sales of RELVAR®/BREO® ELLIPTA®
and ANORO® ELLIPTA®. ANORO®, RELVAR® and BREO® are trademarks of
the GSK group of companies. For more information on Innoviva,
please visit here.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230606005949/en/
Investors & Media: Argot Partners (212) 600-1902
innoviva@argotpartners.com
Innoviva (NASDAQ:INVA)
Historical Stock Chart
From Apr 2024 to May 2024
Innoviva (NASDAQ:INVA)
Historical Stock Chart
From May 2023 to May 2024